Officials in Canada said on 25 February 2021 that Canada's COVID-19 vaccination campaign is ramping up after earlier supply disruptions, Reuters news agency reported on Friday.
Canada's deputy chief public health officer, Howard Njoo, was quoted as telling a briefing that over 240,000 COVID-19 doses were injected last week, the most in more than a month.
"We are seeing positive signs that the rollout is ramping up. ... This is a reflection of greater supply," he said, adding that about 2.9% of Canadians had received at least one dose and this percentage is expected to significantly increase throughout March 2021.
Major General Dany Fortin, in charge of coordinating the COVID-19 vaccine rollout, has said a total of 643,000 doses had been distributed this week, the highest amount yet.
Reportedly, Canada has deals with US pharmaceutical companies Pfizer Inc and Moderna Inc to purchase COVID-19 vaccines, but both companies ran into production problems last month and reduced shipments.
Canada says it is still on track to receive a total of six million doses from Pfizer and Moderna by the end of March 2021 and that anyone who wants a shot can get one by the end of September 2021.
So far, Canada has recorded a total of 21,807 COVID-19 deaths and 855,126 cases.
Pfizer reports positive Phase 3 data for ABRYSVO in adults at risk for RSV disease
Clover Bio announces SCB-1019 vaccine candidate Phase I trial data in initial young adult cohort
Sanofi launches Verorab for rabies prophylaxis in UK
BioVaxys expands patent portfolio for DPX delivery platform and advances DPX SurMAGE
YS Biopharma repays USD40m loan facility
Kintara Therapeutics and TuHURA Biosciences to merge
VGXI names new chief accounting officer
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Valneva launches Phase 1 trial for next-generation Zika vaccine
Circio Holding ASA confirms licensing deal with IOVaxis Therapeutics in China and Singapore
Everest Medicines names new chief medical officer and chief product officer
Pfizer's PREVENAR 20 gains European Commission approval for paediatric pneumococcal vaccine